Genprex(GB:0A8I)
$1.49-0.17 (-10.18%)
GB:0A8I
Genprex financials statements
$1.49
At close:-0.17 (-10.18%)
Genprex (0A8I) Income Statement
0 Followers
Genprex Income Statement
Last quarter (Q3 2026), Genprex's total revenue was $0.00. In Q3, Genprex's net income was $-4.24M. See Genprex’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | |
| $ 0.00 | $ -6.69K | $ -15.00K | $ -25.57K | $ -22.53K | |
| $ 15.52M | $ 21.17M | $ 31.06M | $ 23.81M | $ 20.65M | |
| Depreciation and Amortization | $ 0.00 | $ 6.69K | $ 15.00K | $ 25.57K | $ 22.53K |
| $ -15.49M | $ -21.10M | $ -30.85M | $ -23.72M | $ -20.64M | |
| $ -15.52M | $ -21.17M | $ -31.08M | $ -23.83M | $ -20.67M | |
| $ -713.33K | $ 63.00K | $ 215.11K | $ 90.10K | $ 5.13K | |
| $ -16.23M | $ -21.11M | $ -30.86M | $ -23.74M | $ -20.66M | |
| $ -16.23M | $ -21.11M | $ -30.86M | $ -23.74M | $ -20.66M | |
| Per Share Metrics | |||||
| Basic EPS | $ -382.80 | $ -5872.98 | $ -24838.00 | $ -21780.00 | $ -19305.00 |
| Diluted EPS | $ -382.80 | $ -5872.98 | $ -24816.00 | $ -21780.00 | $ -19305.00 |
| Weighted Average Shares Outstanding | 42.40K | 3.64K | 1.24K | 1.09K | 1.07K |
| Weighted Average Shares Outstanding (Diluted) | 42.40K | 3.64K | 1.24K | 1.09K | 1.07K |
Currency in USD

